Cubist Systematic Strategies, LLC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 2 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$2,236,000
+12.0%
32,834
-47.5%
0.01%
+8.3%
Q2 2022$1,997,000
+429.7%
62,489
+473.8%
0.01%
+300.0%
Q1 2022$377,000
-65.9%
10,891
-71.2%
0.00%
-72.7%
Q4 2021$1,106,000
-75.6%
37,790
-78.7%
0.01%
-80.7%
Q3 2021$4,530,000
+52.4%
177,799
+109.4%
0.06%
+67.6%
Q2 2021$2,973,000
-6.0%
84,903
+9.4%
0.03%
-15.0%
Q1 2021$3,164,000
+34.0%
77,634
+42.3%
0.04%
+25.0%
Q4 2020$2,362,000
+29.1%
54,539
+64.3%
0.03%
+18.5%
Q3 2020$1,830,000
-43.7%
33,192
-35.5%
0.03%
-51.8%
Q2 2020$3,250,000
+242.5%
51,487
+177.1%
0.06%
+115.4%
Q1 2020$949,000
-48.6%
18,581
-20.1%
0.03%
-23.5%
Q4 2019$1,848,000
+190.6%
23,249
+77.4%
0.03%
+161.5%
Q3 2019$636,000
-30.3%
13,105
-24.5%
0.01%
-23.5%
Q2 2019$913,000
+155.0%
17,362
+84.5%
0.02%
-15.0%
Q3 2018$358,000
-2.2%
9,410
+16.1%
0.02%
+11.1%
Q2 2018$366,000
+1162.1%
8,102
+1005.3%
0.02%
+800.0%
Q4 2017$29,000
-85.6%
733
-88.8%
0.00%
-81.8%
Q3 2017$202,000
-9.8%
6,519
-20.5%
0.01%
-21.4%
Q2 2017$224,000
+44.5%
8,205
+94.7%
0.01%
+27.3%
Q1 2017$155,000
+72.2%
4,214
-25.6%
0.01%
+120.0%
Q1 2016$90,0005,6650.01%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q4 2022
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 356,270$24,262,00023.36%
Twin Securities, Inc. 376,669$25,651,00011.94%
Paradigm Biocapital Advisors LP 1,175,879$80,077,00010.68%
Chicago Capital Management, LLC 246,246$16,769,0009.12%
HARVEST MANAGEMENT LLC 141,500$9,636,0007.78%
Fernwood Investment Management, LLC 174,724$11,899,0005.02%
ArchPoint Investors 168,725$11,490,0004.69%
HAVENS ADVISORS LLC 46,000$3,133,0004.69%
Perceptive Advisors 2,322,247$158,145,0004.59%
Crabel Capital Management, LLC 112,680$7,674,0004.48%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders